The AHA today expressed support for the Excellence in Mental Health and Addiction Treatment Expansion Act (H.R.1767/S. 824), bipartisan legislation that would renew and expand an innovative demonstration program that expands access to treatment of mental illnesses and substance use disorders through community-based clinics.
 
To increase access to care, Congress, in the Protecting Access to Medicare Act, authorized demonstration programs in up to eight states to improve community behavioral health services through certified community behavioral health clinics – a new comprehensive treatment model that launched in 2017. Statutory authority for the CCBHC program will end in June 2019 unless Congress acts.
 
“Your timely legislation would renew the CCBHC demonstration program in the original eight states (Minnesota, Missouri, Nevada, New Jersey, New York, Oklahoma, Oregon and Pennsylvania) for two years and expand it to 11 additional states, enabling current patients to continue receiving comprehensive care, and increasing the number of individuals with access to vital services,” AHA said.
 
The legislation was introduced in the House by Reps. Doris Matsui, D-Calif., and Markwayne Mullin, R-Okla., and in the Senate by Sens. Roy Blunt, R-Mo., and Debbie Stabenow, D-Mich.

Headline
The cigarette smoking rate among U.S. adults dropped to 9.9% in 2024, the lowest level ever recorded, according to a report by the New England Journal of…
Headline
America’s hospitals and health systems are deeply committed to providing high-quality, accessible and affordable care, AHA President and CEO Rick Pollack March…
Headline
A study published by BMJ found that glucagon-like peptide-1 (GLP-1) drugs could help reduce the risk of various substance use disorders, including for alcohol…
Headline
Jeremy Fish, M.D., director of the Family Medicine Residency Program at John Muir Health, and Pilar Corcoran-Lozano, behavioral health corps faculty and…
Headline
The Substance Abuse and Mental Health Services Administration announced March 6 that it will award $69.1 million in grants for mental health and suicide…
Headline
The Food and Drug Administration March 5 issued a request for information seeking public comments on potential new standards for in-home opioid disposal…